Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 50

1.

Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.

Tang M, Zhao Y, Liu N, Chen E, Quan Z, Wu X, Luo C.

J Cancer Res Clin Oncol. 2017 May;143(5):793-805. doi: 10.1007/s00432-016-2333-y. Epub 2017 Feb 22.

PMID:
28229220
2.

5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.

Wang X, Chen E, Yang X, Wang Y, Quan Z, Wu X, Luo C.

Oncol Rep. 2016 Mar;35(3):1375-84. doi: 10.3892/or.2015.4492. Epub 2015 Dec 17.

PMID:
26677113
3.

HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.

Shao H, Gu Y, Ding J, Lu P, Ruan T, Lu W.

Tumour Biol. 2016 Feb;37(2):2621-7. doi: 10.1007/s13277-015-4084-9. Epub 2015 Sep 22.

PMID:
26392113
4.

GlialCAM, a CLC-2 Cl(-) channel subunit, activates the slow gate of CLC chloride channels.

Jeworutzki E, Lagostena L, Elorza-Vidal X, López-Hernández T, Estévez R, Pusch M.

Biophys J. 2014 Sep 2;107(5):1105-16. doi: 10.1016/j.bpj.2014.07.040.

5.

Functional analyses of mutations in HEPACAM causing megalencephalic leukoencephalopathy.

Arnedo T, López-Hernández T, Jeworutzki E, Capdevila-Nortes X, Sirisi S, Pusch M, Estévez R.

Hum Mutat. 2014 Oct;35(10):1175-8. doi: 10.1002/humu.22622. Epub 2014 Aug 18.

PMID:
25044933
6.

Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.

Song X, Wang Y, Du H, Fan Y, Yang X, Wang X, Wu X, Luo C.

Prostate. 2014 Jul;74(10):1023-33. doi: 10.1002/pros.22817. Epub 2014 May 8.

PMID:
24811146
7.

Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.

Tao J, Liu Q, Wu X, Xu X, Zhang Y, Wang Q, Luo C.

Int J Med Sci. 2013 Nov 11;10(13):1860-7. doi: 10.7150/ijms.6460. eCollection 2013.

8.

Expanding the spectrum of megalencephalic leukoencephalopathy with subcortical cysts in two patients with GLIALCAM mutations.

Arnedo T, Aiello C, Jeworutzki E, Dentici ML, Uziel G, Simonati A, Pusch M, Bertini E, Estévez R.

Neurogenetics. 2014 Mar;15(1):41-8. doi: 10.1007/s10048-013-0381-x. Epub 2013 Nov 8.

PMID:
24202401
9.

Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.

Pan C, Wu X, Luo C, Yang S, Pu J, Wang C, Shen S.

Urol Int. 2010;85(3):347-54. doi: 10.1159/000318889. Epub 2010 Jul 13.

PMID:
20628239
10.

Megalencephalic leukoencephalopathy with cysts without MLC1 defect.

van der Knaap MS, Lai V, Köhler W, Salih MA, Fonseca MJ, Benke TA, Wilson C, Jayakar P, Aine MR, Dom L, Lynch B, Kálmánchey R, Pietsch P, Errami A, Scheper GC.

Ann Neurol. 2010 Jun;67(6):834-7. doi: 10.1002/ana.21980.

PMID:
20517947
11.

The immunoglobulin-like cell adhesion molecule hepaCAM is cleaved in the human breast carcinoma MCF7 cells.

Zhang T, Moh MC, Lee LH, Shen S.

Int J Oncol. 2010 Jul;37(1):155-65.

PMID:
20514407
12.

Functional significance of the hepaCAM gene in bladder cancer.

He Y, Wu X, Luo C, Wang L, Lin J.

BMC Cancer. 2010 Mar 8;10:83. doi: 10.1186/1471-2407-10-83.

13.

The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.

Lee LH, Moh MC, Zhang T, Shen S.

J Cell Biochem. 2009 Aug 15;107(6):1129-38. doi: 10.1002/jcb.22215.

PMID:
19507233
14.

The immunoglobulin-like cell adhesion molecule hepaCAM modulates cell adhesion and motility through direct interaction with the actin cytoskeleton.

Moh MC, Tian Q, Zhang T, Lee LH, Shen S.

J Cell Physiol. 2009 May;219(2):382-91. doi: 10.1002/jcp.21685.

PMID:
19142852
15.

Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.

Moh MC, Zhang T, Lee LH, Shen S.

Carcinogenesis. 2008 Dec;29(12):2298-305. doi: 10.1093/carcin/bgn226. Epub 2008 Oct 8.

PMID:
18845560
16.

Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation.

Gaudry JP, Arod C, Sauvage C, Busso S, Dupraz P, Pankiewicz R, Antonsson B.

Protein Expr Purif. 2008 Mar;58(1):94-102. Epub 2007 Nov 7.

PMID:
18082421
17.

Ten Novel Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts and a Long-Term Follow-Up Research.

Cao B, Yan H, Guo M, Xie H, Wu Y, Gu Q, Xiao J, Shang J, Yang Y, Xiong H, Niu Z, Wu X, Jiang Y, Wang J.

PLoS One. 2016 Jun 20;11(6):e0157258. doi: 10.1371/journal.pone.0157258. eCollection 2016.

18.

Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.

Jiang XL, Zhang Y, Tan B, Luo CL, Wu XH.

Neoplasma. 2014;61(4):416-23. doi: 10.4149/neo_2014_051.

PMID:
24645843
19.

Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening.

Marchese M, Conti V, Valvo G, Moro F, Muratori F, Tancredi R, Santorelli FM, Guerrini R, Sicca F.

BMC Med Genet. 2014 Feb 27;15:26. doi: 10.1186/1471-2350-15-26.

20.

HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane.

Tan B, Tan J, Du H, Quan Z, Xu X, Jiang X, Luo C, Wu X.

Mol Cell Biochem. 2014 Jun;391(1-2):95-102. doi: 10.1007/s11010-014-1991-9. Epub 2014 Feb 11.

PMID:
24515280

Supplemental Content

Support Center